{"entity":{"type":"insider","cik":"0001557146","url":"/insider/0001557146","json_url":"/insider/0001557146.json","name":"Lloyd-Smith Malcolm","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":26,"first":"2013-06-11","last":"2023-02-08","span_basis":"filed_date"},"name_variants":[{"name":"Lloyd-Smith Malcolm","source":"filing","n_filings":26,"first_seen":"2013-06-11","last_seen":"2023-02-08"}],"transactions":[{"id":7896184,"accession":"0001209191-23-007914","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007914","line_url":"/filing/0001209191-23-007914#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Integration Officer)","role_mark":"O","role_mark_label":"Officer (Chief Integration Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Integration Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":103.8296,"price_display":"103.83","price_state":"stated","total_value":72784.5496,"total_display":"72,784.55","total_whole":"72,785","shares_owned_after":42337.0,"shares_owned_after_display":"42,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-08","scope":"insider"},{"id":7896181,"accession":"0001209191-23-007914","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007914","line_url":"/filing/0001209191-23-007914","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Integration Officer)","role_mark":"O","role_mark_label":"Officer (Chief Integration Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Integration Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13816.0,"shares_display":"13,816","price_per_share":102.3924409597568,"price_display":"102.39","price_state":"stated","total_value":1414653.9643,"total_display":"1,414,653.96","total_whole":"1,414,654","shares_owned_after":41710.0,"shares_owned_after_display":"41,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider","n_lines":2},{"id":7896177,"accession":"0001209191-23-007914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007914","line_url":"/filing/0001209191-23-007914#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Integration Officer)","role_mark":"O","role_mark_label":"Officer (Chief Integration Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Integration Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":105.8153,"price_display":"105.82","price_state":"stated","total_value":84758.0553,"total_display":"84,758.06","total_whole":"84,758","shares_owned_after":29300.0,"shares_owned_after_display":"29,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8627245,"accession":"0001209191-23-006280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006280","line_url":"/filing/0001209191-23-006280#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Integration Officer)","role_mark":"O","role_mark_label":"Officer (Chief Integration Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Integration Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1666.0,"shares_display":"1,666","price_per_share":110.0183,"price_display":"110.02","price_state":"stated","total_value":183290.4878,"total_display":"183,290.49","total_whole":"183,290","shares_owned_after":28582.0,"shares_owned_after_display":"28,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6574101,"accession":"0001209191-22-046070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046070","line_url":"/filing/0001209191-22-046070#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21533.0,"shares_display":"21,533","price_per_share":105.9458,"price_display":"105.95","price_state":"stated","total_value":2281330.9114,"total_display":"2,281,330.91","total_whole":"2,281,331","shares_owned_after":18888.0,"shares_owned_after_display":"18,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-16","scope":"insider"},{"id":6750182,"accession":"0001209191-22-008214","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-008214","line_url":"/filing/0001209191-22-008214#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":79.5301,"price_display":"79.53","price_state":"stated","total_value":55750.6001,"total_display":"55,750.60","total_whole":"55,751","shares_owned_after":18731.0,"shares_owned_after_display":"18,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6750180,"accession":"0001209191-22-008214","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008214","line_url":"/filing/0001209191-22-008214","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2681.0,"shares_display":"2,681","price_per_share":80.72260238716896,"price_display":"80.72","price_state":"stated","total_value":216417.297,"total_display":"216,417.30","total_whole":"216,417","shares_owned_after":17387.0,"shares_owned_after_display":"17,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":3},{"id":5251970,"accession":"0001209191-21-048560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048560","line_url":"/filing/0001209191-21-048560#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16709.0,"shares_display":"16,709","price_per_share":93.8019,"price_display":"93.80","price_state":"stated","total_value":1567335.9471,"total_display":"1,567,335.95","total_whole":"1,567,336","shares_owned_after":15801.0,"shares_owned_after_display":"15,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-29","scope":"insider"},{"id":4882581,"accession":"0001209191-21-010498","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-010498","line_url":"/filing/0001209191-21-010498","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":119.95620588235295,"price_display":"119.96","price_state":"stated","total_value":203925.55,"total_display":"203,925.55","total_whole":"203,926","shares_owned_after":32510.0,"shares_owned_after_display":"32,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider","n_lines":2},{"id":4474232,"accession":"0001209191-21-009121","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009121","line_url":"/filing/0001209191-21-009121","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3261.0,"shares_display":"3,261","price_per_share":116.81361796994787,"price_display":"116.81","price_state":"stated","total_value":380929.2082,"total_display":"380,929.21","total_whole":"380,929","shares_owned_after":31597.0,"shares_owned_after_display":"31,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4474216,"accession":"0001209191-21-009121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009121","line_url":"/filing/0001209191-21-009121#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":865.0,"shares_display":"865","price_per_share":114.1494,"price_display":"114.15","price_state":"stated","total_value":98739.231,"total_display":"98,739.23","total_whole":"98,739","shares_owned_after":29675.0,"shares_owned_after_display":"29,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":5285317,"accession":"0001209191-21-005820","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-005820","line_url":"/filing/0001209191-21-005820","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":119.96861818181819,"price_display":"119.97","price_state":"stated","total_value":131965.48,"total_display":"131,965.48","total_whole":"131,965","shares_owned_after":29002.0,"shares_owned_after_display":"29,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider","n_lines":2},{"id":5285301,"accession":"0001209191-21-005820","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-005820","line_url":"/filing/0001209191-21-005820","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17570.0,"shares_display":"17,570","price_per_share":119.96653361411497,"price_display":"119.97","price_state":"stated","total_value":2107811.9956,"total_display":"2,107,812.00","total_whole":"2,107,812","shares_owned_after":29002.0,"shares_owned_after_display":"29,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":3},{"id":2382933,"accession":"0001209191-20-058551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058551","line_url":"/filing/0001209191-20-058551#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7292,"price_display":"90.73","price_state":"stated","total_value":204775.8044,"total_display":"204,775.80","total_whole":"204,776","shares_owned_after":29002.0,"shares_owned_after_display":"29,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":2545847,"accession":"0001209191-20-045767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045767","line_url":"/filing/0001209191-20-045767#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8646,"price_display":"118.86","price_state":"stated","total_value":268277.4022,"total_display":"268,277.40","total_whole":"268,277","shares_owned_after":26971.0,"shares_owned_after_display":"26,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":3256525,"accession":"0001209191-20-026071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026071","line_url":"/filing/0001209191-20-026071#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.4463,"price_display":"99.45","price_state":"stated","total_value":192329.1442,"total_display":"192,329.14","total_whole":"192,329","shares_owned_after":24941.0,"shares_owned_after_display":"24,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"},{"id":2872047,"accession":"0001209191-20-008513","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-008513","line_url":"/filing/0001209191-20-008513","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28969.0,"shares_display":"28,969","price_per_share":104.563,"price_display":"104.56","price_state":"stated","total_value":3029085.547,"total_display":"3,029,085.55","total_whole":"3,029,086","shares_owned_after":23200.0,"shares_owned_after_display":"23,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider","n_lines":2},{"id":2872032,"accession":"0001209191-20-008513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008513","line_url":"/filing/0001209191-20-008513#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1015.0,"shares_display":"1,015","price_per_share":103.2774,"price_display":"103.28","price_state":"stated","total_value":104826.561,"total_display":"104,826.56","total_whole":"104,827","shares_owned_after":23200.0,"shares_owned_after_display":"23,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":2090233,"accession":"0001209191-20-007686","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-007686","line_url":"/filing/0001209191-20-007686#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1490.0,"shares_display":"1,490","price_per_share":101.5154,"price_display":"101.52","price_state":"stated","total_value":151257.946,"total_display":"151,257.95","total_whole":"151,258","shares_owned_after":22287.0,"shares_owned_after_display":"22,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-07","scope":"insider"},{"id":2090231,"accession":"0001209191-20-007686","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-007686","line_url":"/filing/0001209191-20-007686","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1948.0,"shares_display":"1,948","price_per_share":103.04560112936345,"price_display":"103.05","price_state":"stated","total_value":200732.831,"total_display":"200,732.83","total_whole":"200,733","shares_owned_after":20455.0,"shares_owned_after_display":"20,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider","n_lines":2},{"id":8121048,"accession":"0001209191-19-053286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053286","line_url":"/filing/0001209191-19-053286#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9956.0,"shares_display":"9,956","price_per_share":90.8484,"price_display":"90.85","price_state":"stated","total_value":904486.6704,"total_display":"904,486.67","total_whole":"904,487","shares_owned_after":19613.0,"shares_owned_after_display":"19,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-14","filed_date":"2019-10-16","scope":"insider"},{"id":7787669,"accession":"0001209191-19-008643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-008643","line_url":"/filing/0001209191-19-008643#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":920.0,"shares_display":"920","price_per_share":83.5802,"price_display":"83.58","price_state":"stated","total_value":76893.784,"total_display":"76,893.78","total_whole":"76,894","shares_owned_after":19238.0,"shares_owned_after_display":"19,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-06","filed_date":"2019-02-08","scope":"insider"},{"id":8311508,"accession":"0001209191-19-007854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-007854","line_url":"/filing/0001209191-19-007854","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1272.0,"shares_display":"1,272","price_per_share":88.14353820754717,"price_display":"88.14","price_state":"stated","total_value":112118.5806,"total_display":"112,118.58","total_whole":"112,119","shares_owned_after":16574.0,"shares_owned_after_display":"16,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-06","scope":"insider","n_lines":2},{"id":6765763,"accession":"0001209191-18-057771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-057771","line_url":"/filing/0001209191-18-057771#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":110.0,"price_display":"110.00","price_state":"stated","total_value":363000.0,"total_display":"363,000.00","total_whole":"363,000","shares_owned_after":15318.0,"shares_owned_after_display":"15,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-08","scope":"insider"},{"id":6765756,"accession":"0001209191-18-057771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057771","line_url":"/filing/0001209191-18-057771#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":110.0168,"price_display":"110.02","price_state":"stated","total_value":627095.76,"total_display":"627,095.76","total_whole":"627,096","shares_owned_after":15318.0,"shares_owned_after_display":"15,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-08","scope":"insider"},{"id":6816797,"accession":"0001209191-18-008217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-008217","line_url":"/filing/0001209191-18-008217#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":960.0,"shares_display":"960","price_per_share":83.1902,"price_display":"83.19","price_state":"stated","total_value":79862.592,"total_display":"79,862.59","total_whole":"79,863","shares_owned_after":13982.0,"shares_owned_after_display":"13,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6514146,"accession":"0001209191-18-001889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-001889","line_url":"/filing/0001209191-18-001889#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18084.0,"shares_display":"18,084","price_per_share":77.5173,"price_display":"77.52","price_state":"stated","total_value":1401822.8532,"total_display":"1,401,822.85","total_whole":"1,401,823","shares_owned_after":13017.0,"shares_owned_after_display":"13,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4942787,"accession":"0001209191-17-034632","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-034632","line_url":"/filing/0001209191-17-034632#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4980.0,"shares_display":"4,980","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":268920.0,"total_display":"268,920.00","total_whole":"268,920","shares_owned_after":13017.0,"shares_owned_after_display":"13,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-19","filed_date":"2017-05-23","scope":"insider"},{"id":4942778,"accession":"0001209191-17-034632","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-034632","line_url":"/filing/0001209191-17-034632#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4980.0,"shares_display":"4,980","price_per_share":53.26,"price_display":"53.26","price_state":"stated","total_value":265234.8,"total_display":"265,234.80","total_whole":"265,235","shares_owned_after":13017.0,"shares_owned_after_display":"13,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-18","filed_date":"2017-05-23","scope":"insider"},{"id":4444676,"accession":"0001209191-17-026883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-026883","line_url":"/filing/0001209191-17-026883","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13065.0,"shares_display":"13,065","price_per_share":50.422803673938,"price_display":"50.42","price_state":"stated","total_value":658773.93,"total_display":"658,773.93","total_whole":"658,774","shares_owned_after":13221.0,"shares_owned_after_display":"13,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-12","filed_date":"2017-04-13","scope":"insider","n_lines":2},{"id":4775497,"accession":"0001209191-17-008913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-008913","line_url":"/filing/0001209191-17-008913#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116.0,"shares_display":"116","price_per_share":44.61,"price_display":"44.61","price_state":"stated","total_value":5174.76,"total_display":"5,174.76","total_whole":"5,175","shares_owned_after":1082.0,"shares_owned_after_display":"1,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-08","scope":"insider"},{"id":4775491,"accession":"0001209191-17-008913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008913","line_url":"/filing/0001209191-17-008913#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":727.0,"shares_display":"727","price_per_share":43.15,"price_display":"43.15","price_state":"stated","total_value":31370.05,"total_display":"31,370.05","total_whole":"31,370","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":2887129,"accession":"0001209191-16-139726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-139726","line_url":"/filing/0001209191-16-139726#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-02","scope":"insider"},{"id":3084518,"accession":"0001209191-16-125038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-125038","line_url":"/filing/0001209191-16-125038#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":4985609,"accession":"0001209191-13-037650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-037650","line_url":"/filing/0001209191-13-037650#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (SVP, Reg Affairs, Qual & Clin)","role_mark":"O","role_mark_label":"Officer (SVP, Reg Affairs, Qual & Clin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Reg Affairs, Qual & Clin","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":7.85,"price_display":"7.85","price_state":"stated","total_value":109900.0,"total_display":"109,900.00","total_whole":"109,900","shares_owned_after":2332.0,"shares_owned_after_display":"2,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-22","filed_date":"2013-07-23","scope":"insider"},{"id":5429966,"accession":"0001209191-13-031640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031640","line_url":"/filing/0001209191-13-031640#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001557146","owner_name":"Lloyd-Smith Malcolm","owner_display_name":"Lloyd-Smith Malcolm","owner_url":"/insider/0001557146","role":"Officer (SVP, Reg Affairs, Qual & Clin)","role_mark":"O","role_mark_label":"Officer (SVP, Reg Affairs, Qual & Clin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Reg Affairs, Qual & Clin","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":7.44,"price_display":"7.44","price_state":"stated","total_value":29760.0,"total_display":"29,760.00","total_whole":"29,760","shares_owned_after":2332.0,"shares_owned_after_display":"2,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-10","filed_date":"2013-06-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Integration Officer)","n_filings":24,"first_seen":"2016-06-02","last_seen":"2023-02-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Officer (SVP, Reg Affairs, Qual & Clin)","n_filings":2,"first_seen":"2013-06-11","last_seen":"2013-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557146","retrieved_at":"2026-08-23T03:20:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}